UBS Group »

ADC Therapeutics SA shares owned by UBS Group

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $762k 215k 3.54
2025-09-30 $1.0M 262k 4.00
2025-06-30 $2.2M 828k 2.68
2025-03-31 $1.1M 767k 1.42
2024-12-31 $1.8M 885k 1.99
2024-09-30 $126k 40k 3.16
2024-06-30 $67k 21k 3.16
2024-03-31 $229 51 4.50
2023-03-31 $22k 11k 1.95
2022-12-31 $11k 2.9k 3.84
2021-12-31 $49k 2.4k 20.20
2021-06-30 $4.0k 157 25.48
2021-03-31 $4.0k 157 25.48
2020-12-31 $47k 1.5k 32.08
2020-09-30 $5.0k 141 35.46